AtriCure, Inc. (ATRC)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 23.17 |
| Open | 23.08 |
| Bid | 22.98 x 700 |
| Ask | 23.06 x 600 |
| Day's range | 22.92 - 23.58 |
| 52-week range | 22.27 - 59.61 |
| Volume | |
| Avg. volume | 727,680 |
| Market cap | 1.115B |
| Beta (5Y monthly) | 1.37 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
AtriCure's (ATRC) cryoSPHERE+ Probe to Aid in Pain Management
AtriCure (ATRC) unveils its cryoSPHERE+ cryoablation probe, which is intended to reduce freeze times and aid in postoperative pain management.
- Insider Monkey
AtriCure (ATRC) Declined due to Concerns Over Anti-Obesity Drug
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” fourth-quarter investor letter. A copy of the same can be downloaded here. In the quarter the fund returned 9.15% (net), compared to a 12.75% return for the Russell 2000 Growth Index. For the year, the fund returned 15.96% (net) compared to […]
- GuruFocus.com
Chief Legal Officer Karl Dahlquist Sells 8,231 Shares of AtriCure Inc (ATRC)
Karl Dahlquist, Chief Legal Officer of AtriCure Inc (NASDAQ:ATRC), has sold 8,231 shares of the company on March 5, 2024, according to a recent SEC filing.
© 2024 Yahoo. All rights reserved.